Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Camp4 Therapeutics (CAMP) Interest Expenses (2023 - 2024)

Camp4 Therapeutics' Interest Expenses history spans 2 years, with the latest figure at -$145000.0 for Q4 2024.

  • For Q4 2024, Interest Expenses fell 274.7% year-over-year to -$145000.0; the TTM value through Sep 2025 reached -$145000.0, down 274.7%, while the annual FY2025 figure was $192000.0, 481.82% up from the prior year.
  • Interest Expenses for Q4 2024 was -$145000.0 at Camp4 Therapeutics, down from $83000.0 in the prior quarter.
  • Across five years, Interest Expenses topped out at $83000.0 in Q4 2023 and bottomed at -$145000.0 in Q4 2024.